Medical Technology - EU-27

EU-27

Revenue in the Medical Technology market in European Union (EU27) is projected to reach US$122.30bn in 2024.
The market's largest market is Medical Devices with a projected market volume of US$105.90bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.33%, resulting in a market volume of US$151.20bn by 2029.
In global comparison, most revenue will be generated in the United States (US$211.10bn in 2024).

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in EU-27 is experiencing significant growth and development.

Customer preferences: Customers in the EU-27 are increasingly demanding innovative and advanced medical technology products. They are seeking solutions that can improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce healthcare costs. There is a growing demand for medical devices that are user-friendly, portable, and connected to digital platforms. Additionally, customers are placing a greater emphasis on preventive healthcare and personalized medicine, driving the demand for medical technology products that can support these trends.

Trends in the market: One of the key trends in the Medical Technology market in EU-27 is the adoption of digital health solutions. The integration of technology into healthcare has the potential to revolutionize the way healthcare is delivered and managed. Digital health solutions, such as wearable devices, telemedicine, and health monitoring apps, are gaining popularity among both healthcare providers and patients. These solutions enable remote patient monitoring, facilitate early detection and diagnosis of diseases, and empower individuals to take control of their own health. Another trend in the market is the increasing focus on minimally invasive procedures. There is a growing preference for medical devices and technologies that can minimize patient discomfort, reduce hospital stays, and speed up recovery times. Advances in medical technology have led to the development of innovative devices and techniques that allow for less invasive surgeries and procedures. This trend is driven by the desire to improve patient outcomes, enhance the quality of care, and reduce healthcare costs.

Local special circumstances: The Medical Technology market in EU-27 is influenced by the regulatory environment and healthcare systems of individual countries within the region. Each country has its own regulations and reimbursement policies for medical devices, which can impact the adoption and market penetration of new technologies. Additionally, the healthcare systems in EU-27 countries vary in terms of funding, infrastructure, and organization, which can create unique challenges and opportunities for medical technology companies operating in the region.

Underlying macroeconomic factors: The growth and development of the Medical Technology market in EU-27 are also influenced by macroeconomic factors. Factors such as population demographics, healthcare expenditure, and technological advancements play a significant role in shaping the market. The aging population in EU-27 countries is driving the demand for medical technology products and services, as older individuals require more healthcare interventions. Increasing healthcare expenditure and investments in healthcare infrastructure also contribute to the growth of the market. Furthermore, advancements in technology, such as artificial intelligence, robotics, and genomics, are driving innovation in the medical technology sector and creating new opportunities for market players.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.